Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,437 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

A Study of Amivantamab in People With Esophagogastric Cancer

NCT05117931

Conditions
Esophagogastric Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • University of California, Irvine Irvine, California, United States
  • Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

NCT05501886

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology (US Oncology/McKesson) - Goodyear Goodyear, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

NCT05455606

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +6 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

NCT05169567

Conditions
Breast Diseases, Breast Neoplasm, Breast Neoplasms, +8 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
View all 138 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

NCT06059001

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Hospital Vall d´Hebrón Barcelona, Spain
  • ICO Hopsitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Gregorio Marañon Madrid, Spain
View Trial Details

Related conditions